Back to mobile site

PPHM Says Tarvacin Equivalent Plus Radiation Reduces Lung Tumor Growth By Over 95%

April 18, 2005 8:41 AM EDT Send to a Friend
Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM) reported that data will be presented at the American Association for Cancer Research Annual Meeting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login